 Underlining the focus on inorganic growth, French pharma giant Sanofi NASDAQ: SNY announced a big-ticket acquisition just a month after another billion-dollar deal. Sanofi-Kadmon Deal Terms: Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon Holdings, Inc. NASDAQ: KDMN in a 1.9 billion all-cash deal. 